title: Very late thrombosis after implantation of sirolimus eluting stent.
abstract: Stent thrombosis after sirolimus eluting stent implantation has been reported to occur at six hours to 375 days after the procedure and usually within the two weeks after discontinuation of antiplatelet medication. A case is reported of very late stent thrombosis after 17 months of sirolimus eluting stent implantation and eight months after clopidogrel discontinuation despite aspirin continuation. This case underlines the possible need for long term antiplatelet medication among patients receiving sirolimus eluting stents.
authors.affiliation: Athens Euroclinic, Athens, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Karvouni
authors.forename: S
authors.initials: S
authors.lastname: Korovesis
authors.forename: D G
authors.initials: DG
authors.lastname: Katritsis
mesh_terms: D000328:Adult; D001241:Aspirin / Q000008:administration & dosage; D001807:Blood Vessel Prosthesis; D002404:Catheterization / Q000379:methods; D000077144:Clopidogrel; D017023:Coronary Angiography / Q000379:methods; D023903:Coronary Restenosis / Q000209:etiology; D023921:Coronary Stenosis / Q000628:therapy*; D003328:Coronary Thrombosis / Q000209:etiology*; D004343:Drug Implants; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011475:Prosthesis Failure; D019233:Retreatment; D020123:Sirolimus / Q000008:administration & dosage; D015607:Stents / Q000009:adverse effects*; D013988:Ticlopidine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D013997:Time Factors
chemical_list: D004343:Drug Implants; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin; D020123:Sirolimus